In Bangladesh, the current pregnant women living with hiv antiretroviral therapy coverage for pmtct is 4%, which reflects a decrease of 4% (-50.0%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Bangladesh
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Bangladesh
PMTCT antiretroviral therapy coverage
More indicators for Bangladesh
Male unintentional poisoning
0.3
0.0
(2019)
Female wasting in children
11.4%
+2.2%
(2022)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar112
+intl dollar13
(2021)
Birth registration
56%
+30.8%
(2019)
Contraceptive modern method prevalence
59.1%
+7.2%
(2019)
Bangladesh PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 4% | -4% |
| 2021 | 8% | +4% |
| 2020 | 4% | -2% |
| 2019 | 6% | -2% |
| 2018 | 8% | +2% |
| 2017 | 6% | +1% |
| 2016 | 5% | 0% |
| 2015 | 5% | -1% |
| 2014 | 6% | +1% |
| 2013 | 5% | +1% |
| 2012 | 4% | +1% |
| 2011 | 3% | -3% |
| 2010 | 6% | +1% |
| 2009 | 5% | +1% |
| 2008 | 4% | +2% |
| 2007 | 2% | +1% |
| 2006 | 1% | +1% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |